NOVEL COMPOUNDS

The present invention is directed to crystalline forms of a compound which has retinoid-related orphan receptor gamma (RORγ) modulator activity, processes for their preparation, pharmaceutical compositions containing the same and their use in therapy.

Saved in:
Bibliographic Details
Main Authors CAMPBELL Amanda Jennifer, HARRISON Stephen Anthony, LE Joelle, BIRAULT Veronique
Format Patent
LanguageEnglish
Published 08.09.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to crystalline forms of a compound which has retinoid-related orphan receptor gamma (RORγ) modulator activity, processes for their preparation, pharmaceutical compositions containing the same and their use in therapy.
Bibliography:Application Number: US201415031323